The global cardiac cannula market was valued at USD 271.9 million in 2025 and is expected to reach USD 288.7 million in 2026. The market is forecast to expand to USD 447.2 million by 2033, representing a 6.5% CAGR between 2026 and 2033. North America was the leading regional market in 2025, accounting for 37.9% of global revenue.

According to estimates from Grand View Research, increasing cardiovascular disease prevalence, a growing number of cardiac surgical procedures, and continued improvements in extracorporeal circulation technologies are supporting demand for cardiac cannulas worldwide.

What Is Driving Cardiac Cannula Market Growth?

The rising global burden of cardiovascular diseases is increasing the number of patients requiring surgical and interventional cardiac procedures. This, in turn, is creating greater demand for dependable cannulation products used to establish and maintain blood flow during complex cardiac operations.

The expanding volume of coronary artery bypass procedures, valve replacement surgeries, heart transplants, and other cardiac interventions is particularly important to market development. Hospitals and specialized cardiac centers require cannulas that can provide reliable blood flow while supporting patient safety throughout surgical procedures.

Another important growth factor is the increasing adoption of minimally invasive and robotic-assisted cardiac procedures. These techniques are encouraging manufacturers to develop cannulas with improved performance, optimized configurations, and enhanced material characteristics. Advances in cannula design are also helping address the requirements of increasingly complex cardiovascular interventions.

The growing availability of advanced cardiac care services in emerging economies is expected to create additional opportunities for market participants. Meanwhile, improvements in extracorporeal circulation systems are encouraging the development and adoption of higher-performance cannulation technologies.

Download a free sample report or claim your copy of this full market intelligence report

Cardiac Cannula Market: Segment and Regional Highlights

Market performance varies according to product type, application, material, and geography.

• Product: Arterial cannulas represented the largest revenue share in 2025.
• Application: Cardiopulmonary bypass (CPB) accounted for the largest revenue share in 2025.
• Material: Polyvinyl chloride (PVC) was the leading material segment in 2025.
• Largest region: North America led the global market with a 37.9% revenue share in 2025.
• Fastest-growing region: Asia Pacific is projected to record the highest CAGR from 2026 to 2033.
• Leading country: The U.S. accounted for the largest country-level market share in 2025.

Asia Pacific is expected to gain momentum during the forecast period as healthcare infrastructure expands and access to advanced cardiovascular procedures improves across the region.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Cardiac Cannula Market Size at a Glance

Competitive Landscape

The cardiac cannula market includes established medical device manufacturers and specialized cardiovascular technology companies competing through product development, technology improvements, portfolio expansion, and strategic initiatives.

Key companies profiled in the market include:

• Medtronic
• Edwards Lifesciences Corporation
• Braile Biomédica
• BD (Becton, Dickinson & Company)
• Surge Cardiovascular
• LivaNova PLC
• Getinge
• EUROSETS
• INVAMED
• Cardinal Health

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.